Trial Profile
Effectiveness of a Subcutaneously Administered Long-Acting Insulin Detemir Added to Insulin Drip Therapy as Compared With Standard Insulin Drip Treatment.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Oct 2012 Planned end date changed from 1 Sep 2011 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 05 Sep 2010 New trial record